- Latest week
- 17 Jul 2026
- Close
- 99.000000
- Fair value
- 109.841923
- Next-week expectancy
- Negative 2.93%
ARDX Chart Pack
Ardelyx, Inc.
Chart Summary
Over the latest 12 completed weeks ending 2026-07-17, ARDX fell 23.14%, moving from 128.80 to 99.00. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 5 of the last 12 weeks. Relative Strength is -19.54 and has softened across the 12-week window. Market Dynamics is -1.08 on the latest week. Next-week expectancy is negative at 2.93% based on similar historical setup states.
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 99.00
- 12-Week Change
- -23.14%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 2.93%
- Signal Weeks
- 5 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -19.54
- Market Dynamics
- -1.08
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 99.00
- 12-Week Change
- -23.14%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 2.93%
- Signal Weeks
- 5 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -19.54
- Market Dynamics
- -1.08
Over the latest 12 completed weeks ending 2026-07-17, ARDX fell 23.14%, moving from 128.80 to 99.00. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 5 of the last 12 weeks. Relative Strength is -19.54 and has softened across the 12-week window. Market Dynamics is -1.08 on the latest week. Next-week expectancy is negative at 2.93% based on similar historical setup states.
Industry Peers
Mexico equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| BMRN BioMarin Pharmaceutical Inc. | MEX | 17 Jul 2026 | 959.00 | 959.00 | 959.00 | 959.00 | 0.00% |
| BNTXN BioNTech SE | MEX | 17 Jul 2026 | 1590.00 | 1590.00 | 1590.00 | 1590.00 | 0.00% |
| DNA Ginkgo Bioworks Holdings, Inc. | MEX | 17 Jul 2026 | 170.00 | 170.00 | 170.00 | 170.00 | 0.00% |
| INCY Incyte Corporation | MEX | 17 Jul 2026 | 2067.00 | 2067.00 | 2067.00 | 2067.00 | 0.00% |
| KYNB Kyntra Bio, Inc. | MEX | 17 Jul 2026 | 127.90 | 127.90 | 127.90 | 127.90 | 0.00% |
| REGN Regeneron Pharmaceuticals, Inc. | MEX | 17 Jul 2026 | 10835.99 | 10835.99 | 10835.99 | 10835.99 | 0.00% |
| SMMT Summit Therapeutics Inc. | MEX | 17 Jul 2026 | 290.12 | 290.12 | 290.12 | 290.12 | 0.00% |
| SRPT SAREPTA THERAPEUTICS INC | MEX | 17 Jul 2026 | 294.00 | 294.00 | 294.00 | 294.00 | 0.00% |
| VRTX Vertex Pharmaceuticals Incorporated | MEX | 17 Jul 2026 | 8474.00 | 8474.00 | 8295.00 | 8319.00 | -1.83% |
| CRSPN CRISPR Therapeutics AG | MEX | 17 Jul 2026 | 880.00 | 880.30 | 850.00 | 850.00 | -3.41% |
| INO Inovio Pharmaceuticals, Inc. | MEX | 17 Jul 2026 | 21.26 | 21.26 | 20.00 | 20.00 | -5.93% |
| ALT1 Altimmune, Inc. | MEX | 17 Jul 2026 | 53.40 | 53.40 | 50.09 | 50.09 | -6.20% |
| PROK ProKidney Corp. | MEX | 17 Jul 2026 | 29.50 | 29.50 | 27.50 | 27.59 | -6.47% |
| MRNA Moderna, Inc. | MEX | 17 Jul 2026 | 1195.00 | 1207.00 | 1100.00 | 1100.00 | -7.95% |
| OCGN Ocugen, Inc. | MEX | 17 Jul 2026 | 26.00 | 26.00 | 23.88 | 23.88 | -8.15% |
| NVAX Novavax, Inc. | MEX | 17 Jul 2026 | 156.50 | 156.50 | 142.50 | 142.63 | -8.86% |